FREE TRIIODOTHYRONINE (T3) - ANVISA Registration 80102513519
Access comprehensive regulatory information for FREE TRIIODOTHYRONINE (T3) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80102513519 and manufactured by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MรDICOS LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ORTHO-CLINICAL DIAGNOSTICS, SIEMENS HEALTHCARE DIAGNOSTICS INC., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80102513519
25351131079202527
04718143000194
Company Information
Dates and Status
Sep 15, 2025
VIGENTE
09/18/2025 19:00:01
ORTHO-CLINICAL DIAGNOSTICSโข United Kingdom
SIEMENS HEALTHCARE DIAGNOSTICS INC.โข United States of America
SHENZHEN LIFOTRONIC TECHNOLOGY CO., LTD.โข China
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS LTD.โข United Kingdom
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTDโข China
TRIIODOTIRONINA (T3) LIVRE
SMART FT3
XIAMEN BIOTIME BIOTECHNOLOGY CO., LTD.
80074330037
Apr 28, 2025
TRIIODOTIRONINA (T3) LIVRE
Free T3 Chemiluminescent Immunoassay Kit
MACCURA BIOTECHNOLOGY CO LTD
82444370220
Apr 07, 2025
TRIIODOTIRONINA (T3) LIVRE
CELER FINECARE T3 LIVRE TESTE QUANTITATIVO
GUANGZHOU WONDFO BIOTECH CO. LTD
80537410132
Mar 17, 2025
TRIIODOTIRONINA (T3) LIVRE
Free T3 Quantitative Test Kit (Time-Resolved FIA)
ZHEJIANG ORIENT GENE BIOTECH CO., LTD.
82444370118
Jul 22, 2024
TRIIODOTIRONINA (T3) LIVRE
Famรญlia FT3 Livre (CLIA)
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD
80943610202
Apr 29, 2024

